Control of microorganisms by effective cleaning processes is important for both non-sterile and sterile manufacturing processes. This interactive live training will focus on the issues involved with bioburden and other related microbiological topics for cleaning validation. It will start with a discussion of why we address microbiological issues in cleaning validation, as well as ways to control bioburden. It will then cover setting limits, sampling, and sampling recovery studies. A major focus of microbiological issues for many regulatory guidelines is prevention of bioburden proliferation following cleaning and before use. Various clean hold time issues, such as ways to minimize proliferation and to set acceptance criteria, will be addressed. Bioburden in cleaning validation is also one of the main ways that companies can leverage data from other studies based on the new FDA process validation guideline. Finally, related biological concerns, such as endotoxin, will be discussed.
Learning Benefits:
Who should attend:
This live training webinar is applicable to drug product manufacturers and API manufacturers, including biopharmaceutical manufacturers. The following individuals or disciplines involved in process equipment cleaning validation will benefit from attending this live webinar:
Dr. Rizwan Sharnez is a biotech, pharmaceutical and medical device consultant and founder of BioSeparations Inc. and Validation Solutions. He has over 30 years of technical and leadership experience in the development, validation, monitoring and life-cycle management of biopharmaceutical processes. His work experience spans several companies, including Merck, Bristol-Myers Squibb and Amgen, where he served as Sc. Director until 2017. Dr. Sharnez has consulted with over 50 clients including Alexion Pharmaceuticals, Amgen, Agilent Technologies, AGC Biologics, The Gates Foundation, Genentech,...